Background information. Heat-inducible Hsp72 is the founding member of the Hsp70 (heat shock proteins of 70 kDa) family of molecular chaperones. It is localized primarily in cytoplasm and nucleus but is also found extracellularly. The source of e-Hsp72 (extracellular Hsp72) is not precisely identified and may not be the same in every situation. A number of studies demonstrated that e-Hsp72 plays an important role in cell survival, tumour rejection and immune response. However, currently little is known about regulation of e-Hsp72 function. In cells, Hsp72 is controlled by co-chaperones. An abundant co-chaperone, HspBP1 (Hsp72-binding protein 1) was found extracellularly in the serum. In the present study we analysed the secretion and function of e-HspBP1 (extracellular HspBP1).
Introduction
Hsp70 (heat shock proteins of 70 kDa) constitute a family of molecular chaperones essential for cell physiology, pathophysiology, and survival (Hartl and Hayer-Hartl, 2002; Guzhova and Margulis, 2006) . The founding member of the family, Hsp72 (HSPA1A) is induced by heat and other stresses. Hsp72 prevents the aggregation of heat-denatured or www.biolcell.org | Volume 101 (6) | Pages [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] Biology of the Cell www.biolcell.org unfolded proteins and assists their refolding (Bukau and Horwich, 1998) . Hsp72 is normally located in the cytoplasm and nucleus and does not posses an apparent extracellular export signal. However, the presence of Hsp72 in various extracellular locations has been demonstrated (Guzhova et al., 2001; HunterLavin et al., 2004; Lancaster and Febbraio, 2005) . Previous studies indicated both immunomodulatory and pro-survival functions of extracellular Hsp72 (eHsp72). It has been shown that e-Hsp72 can promote tumour rejection, elicit an autoimmune response, or stimulate both adaptive and innate immunity (Johnson and Fleshner, 2006; Calderwood et al., 2007) . In addition, e-Hsp72 enhanced stress tolerance of immune and neuronal cells in culture (Guzhova et al., 2001) . Nevertheless, the e-Hsp72 function is still poorly understood and the mechanism of Hsp72 export is debated.
The function of Hsp72 inside a cell fundamentally relies on accessory proteins called co-chaperones. A co-chaperone, HspBP1 (Hsp72-binding protein 1), was identified in human blood . HspBP1 accelerates the nucleotide exchange on the ATPase domain of Hsp72 and thus can modulate the chaperone activity of the latter (Raynes and Guerriero, 1998; McLellan et al., 2003) . The present study is focused on mechanisms of HspBP1 export and function outside the cell. We report that both HspBP1 and Hsp72 are associated with CgA (chromogranin A)-positive intracellular vesicles following a brief heat shock or incubation with U73122, an inhibitor of PLC (phospholipase C). We found that under these conditions, both proteins were also released into the cell culture medium and e-HspBP1 (extracellular HspBP1) was physically associated with e-Hsp72. Furthermore, e-HspBP1 functionally interacted with e-Hsp72. Finally, purified r-HspBP1 (recombinant HspBP1) enhanced e-Hsp72-mediated phosphorylation of EGFR (epidermal growth factor receptor) and its down-stream targets, ERK1 (extracellular signal-regulated kinase 1) and ERK2.
Our present results suggest that in response to stress A431 cells activate an autoregulatory mechanism that involves the secretion of the major molecular chaperone Hsp72 and co-chaperone HspBP1. These extracellular proteins in turn activate EGFR, which regulates cell growth and proliferation and significantly promotes the survival of tumour cells. Therefore, e-Hsp72/e-HspBP1-mediated activation of EGFR can be a novel mechanism conferring the protection of cells to stress.
Results and discussion
A431 squamous carcinoma cells release HspBP1 during heat stress or inhibition of phospholipase C In previous reports we have shown that cells can produce e-Hsp72 in response to heat shock or treatment with U73122, a pharmacological inhibitor of PLC. We have demonstrated that A431 keratinocytederived human squamous carcinoma cells and HaCaT minimally transformed human keratinocytes can dynamically export Hsp72 (Evdonin et al., 2004 (Evdonin et al., , 2006a ). HspBP1, a major Hsp72-binding protein, was also found extracellularly (Raynes and Guerriero, 1998; Raynes et al., 2006) . We have hypothesized that e-HspBP1 can be found in the cell culture medium under conditions known to induce Hsp72 release, namely after mild heat shock and PLC inhibition. In order to detect e-HspBP1, A431 cells were cultured under the specified conditions and conditioned media were collected and incubated with anti-HspBP1 antibody conjugated to agarose beads. The presence of HspBP1 was analysed by Western blotting using a antibody specific to HspBP1 (Figure 1A) . Normally, the conditioned cell culture medium contained low amount of e-HspBP1; however, the level of e-HspBP1 considerably increased after 30 min of 42
• C heat shock or the treatment with 1 μM U73122. U73343, an inactive U73122 analogue, did not have effect on e-HspBP1 production, suggesting the involvement of PLC in the export of this chaperone. As expected, A431 cells released Hsp72 as well, and e-Hsp72 could be detected in anti-HspBP1 immunoprecipitates ( Figure 1A ). To control for a non-specific absorption, conditioned media were also incubated with agarose beads conjugated to BSA (BSA-agarose). Under tested conditions, BSA-agarose retained neither HspBP1 nor Hsp72 (results not shown). The present results suggest that these two proteins form a complex in the extracellular milieu.
A431 cells regulate the level and localization of cellular HspBP1 during and after stress
Treatments used in this study do not damage cells. Specifically, micromolar concentrations of U73122 did not affect the viability of A431 cells, as shown in our previous work (Evdonin et al., 2004 , see also Wang et al., 2001) . Heat shock (30 min at 42
• C) did not decrease A431 cell viability for at least 24 h, as determined by the Trypan Blue exclusion method (results not shown). In addition, MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide]/formazan staining did not reveal any significant changes in the number of live cells up to 24 h after either treatment (results not shown). To elucidate the mechanism of HspBP1 appearance in the cell culture medium, changes in its cellular content and localization were analysed. The level of cellular HspBP1 was considerably reduced in response to the heat shock or 1 μM U73122, whereas the level of the reference protein, α-tubulin, did not change ( Figure 1B ). The level of cellular Hsp72 also decreased in response to the treatments ( Figure 1C) . Importantly, the inactive U73343 analogue did not affect either HspBP1 or Hsp72 ( Figures 1B and 1C ).
Subsequent analysis of HspBP1 levels during a 24 h recovery after the heat stress has revealed that A431 cells can quickly restore HspBP1 levels. At 3 h after the heat shock, the amount of HspBP1 returned to nearly pre-treatment level, and at 6 h was fully recovered based on Western blotting analysis and densitometry estimation of HspBP1/α-tubulin ratio ( Figures 1D and 1E ). These observations may explain the absence of detectable changes in the level of HspBP1 2 h after heat stress in HL60 promyelocytic cells (Gottwald et al., 2006) . On the basis of the present results, we suggest that HspBP1 levels should be assessed during or immediately after the stress.
Finally, cellular distribution of HspBP1 changed dramatically in heated cells compared with the untreated control, as demonstrated by indirect immunofluorescence microscopy ( Figures 1F-1H ). The intense cytoplasmic staining of HspBP1, characteristic to control cells, was lost in the heat-treated cells and most of the HspBP1-positive fluorescence was observed in vesicles located at the cell periphery (Figures 1F and 1G) . Following recovery, the original HspBP1 distribution was restored ( Figure 1H) .
The present results demonstrate that heat stressmediated changes in cellular HspBP1 content and localization are highly dynamic. The observed release of both Hsp72 and HspBP1 into the medium is not due to the general damage of cells. Instead, our results suggest that A431 cells may use a specific mechanism to export these proteins under the stress conditions.
A431 cells export HspBP1 via secretory-like granules
To clarify the mechanism of the HspBP1 release from A431 cells, we have studied changes in the intracellular distribution of the protein before and after the treatments. Using indirect immunofluorescence microscopy, we found that untreated A431 cells exhibit a fine granular distribution of HspBP1 throughout the cytoplasm ( Figure 2B ). However, in both the heat shock and U73122 treated cells there is a spectacular re-distribution of HspBP1 into structures located primarily at the cell periphery, and the HspBP1 fluorescence in the remainder of the cytoplasm diminished considerably ( Figures 2E and 2H ). This pattern closely resembles changes in Hsp72 localization reported in our earlier work (Evdonin et al., 2006a) . Indeed, both the heat stress and treatment with U73122 induced the re-localization of HspBP1 into Hsp72-positive structures (Figures 2A-2I ). It was also noted that, without the indicated treatments, HspBP1 staining only partially overlaps with Hsp72 staining, suggesting that under normal conditions subsets of the proteins interact with each other (Figures 2A-2C) .
Previously we have shown that both heat stress and U73122 treatment cause the re-distribution of intracellular Hsp72 into vesicles containing CgA (Evdonin et al., 2006a) . CgA is a specific marker of dense core secretory granules and it can be found in a variety of cells of endocrine, exocrine, or neuroendocrine origin (Zhang et al., 2006) . Non-secreting cells are often able to generate secretory-like granules, especially if cells express both granins and cargo proteins of the regulated secretory pathway. Many of the highly transformed carcinomas of non-secretory origin are known to secrete CgA (Wu et al., 2000; Beuret et al., 2004 ). As we demonstrated previously, A431 cells express CgA, secrete it into the medium, and form the secretory-like granules under U73122 treatment (Evdonin et al., 2006a ). Here we show that both Hsp72 and HspBP1 are re-located into CgA-positive granules under heat stress and U73122 treatment ( Figures 2J-2L ). Note that, in spite of the vivid similarity of localization patterns, some of CgApositive structures lack HspBP1 signal, re-enforcing the specificity of our staining protocol.
The co-localization of Hsp72 and HspBP1 in the secretory-like vesicles and their physical association in extracellular media suggest a common mechanism of secretion. The export of Hsp72 can be inhibited by the incubation of A431 cells with BFA (brefeldin A; Evdonin et al., 2006a) . Therefore, to analyse the HspBP1 export pathway, A431 cells were pre-treated with 10 μg/ml BFA for 30 min and incubated at 
42
• C or 37
• C for another 30 min. HspBP1 content in the media and whole cell extracts was assessed using Western blotting in untreated, BFA-treated and heat shock-treated cells (Figure 3) . BFA prevented heat shock-mediated accumulation of e-HspBP1 in the medium and a reduction in the cellular HspBP1, but did not affect the basal levels of HspBP1 either in the media or in the cells (Figures 3A and 3B). Finally, BFA impaired heat shock-mediated redistribution of HspBP1 ( Figures 3C-3F ). The mechanism of HspBP1 release has not been studied before; however, a number of publications addressed the mechanism of Hsp72 release. An exosome-mediated export of Hsp72 has been demonstrated in several publications (Bausero et al., 2005; Lancaster and Febbraio, 2005) , whereas other studies have shown the involvement of a non-classical endolysosomal pathway (Hunter-Lavin et al., 2004; Mambula and Calderwood, 2006) . It is not currently clear whether cells of various origins use the same or different mechanisms to export Hsp72. The fungal metabolite BFA inhibits the budding of intracellular vesicles, resulting in the collapse of Golgi into the ER (endoplasmic reticulum). BFA also blocks the formation of new vesicles in the TGN (transGolgi network), but does not affect the fusion of preformed secretory granules with plasma membrane. Accordingly, our experiments indicate that in A431 cells both Hsp72 and HspBP1 can be targeted to the exocytosis pathway involving the ER-Golgi system. It is likely that both Hsp72 and HspBP1 enter CgA-positive secretory-like vesicles during the heat stress or U73122 treatment. The U73122 dependence indicates the PLC involvement in the export of the chaperones. PLC is a key enzyme in the inducible vesicular transport from the TGN to the plasma membrane. The aminosteroid U73122 blocks agonist-stimulated hydrolysis of phospholipids catalysed by PLC and inhibits inducible export from TGN (Diaz Anel, 2007) . However, in cells, U73122-mediated inhibition of PLC occurs within minutes of treatment. Longer incubations were shown to transform U73122 into a weak PLC agonist and the treatment of cells with U73122 for more than 10 min may result in a dose-dependent stimulation of exocytosis (Horowitz et al., 2005) . U73122 can induce the release of Ca 2+ from the intracellular stores at the secretory pole of polarized mouse pancreatic acinar cells and promote the trafficking of cargo-filled vesicles between TGN and the cell surface (Mogami et al., 1997) . Likewise, U73122 increases the basal secretion of prolactin and lutenizing hormone in rat pituitary cells (Smallridge et al., 1992; Zheng et al., 1995) . Importantly, U73343, a chemical analogue of U73122, did not inhibit PLC and did not affect the secretion in these studies. Similarly, in the present experiments, U73343 had no influence on Hsp72 or HspBP1 export (Figures 1A-1C) .
Studies demonstrated that other chaperones are exported from cells using the secretory pathway. For example, mitochondrial Hsp60 was located in insulin secretory granules, zymogen granules and growth hormone granules (Brudzynski et al., 1992; Cechetto et al., 2000) , while a J-domain co-chaperone, cysteine string protein CSP, was found in marine ray cholinergic synaptic vesicles and rat pancreas zymogen granules (Braun and Scheller, 1995) . Although, further studies are needed to ascertain the exact mechanism of Hsp72 and HspBP1 export, our present results suggest that A431 cells use the ER-Golgi-TGN pathway to secrete both HspBP1 and Hsp72 in response to stress.
Extracellular HspBP1 augments e-Hsp72 signalling activity
Our earlier study demonstrated that both the purified Hsp72 and the medium collected from the heatstressed cells induces tyrosine phosphorylation of EGFR (Evdonin et al., 2006b ). However, e-Hsp72 was less potent than the conditioned medium, so we thought that additional factors, such as cochaperones, might be involved in the e-Hsp72-mediated phosphorylation of EGFR. To test the influence of HspBP1 on the e-Hsp72-mediated phosphorylation of EGFR, A431 cells were treated with various amounts of purified r-HspBP1, purified bovine Hsp72 (e-Hsp72), or a mixture of the two proteins. Total EGFR was immunoprecipitated from cellular extracts with anti-EGFR antibody and the amount of the phosphorylated form of EGFR was detected in Western blotting using antibody specific to phosphotyrosine. As expected, EGFR tyrosine phosphorylation was enhanced by e-Hsp72, but this phosphorylation was considerably augmented by the addition of r-HspBP1 ( Figure 4A) . Without e-Hsp72, r-HspBP1 did not induce EGFR tyrosine phosphorylation. By changing the concentration of r-HspBP1, while keeping e-Hsp72 concentration constant (100 ng/ml), it has been determined that equimolar amounts of the two proteins induce maximal EGFR tyrosine phosphorylation, whereas both higher and lower concentrations of e-HspBP1 were less effective ( Figure 4B ). Neither denatured (boiled) nor N-terminal deletion mutant r-HspBP1 had influence on EGFR phosphorylation in the tested concentration range (20-1000 ng/ml). The HspBP1 deletion mutant lacking 83 N-terminal amino acids can still bind Hsp72 (McLellan et al., 2003) , therefore, the N-terminal domain may play a regulatory role in e-Hsp72 activity.
To ensure that the EGFR tyrosine phosphorylation leads to the actual activation of the EGFR signalling pathway, we have analysed the phosphorylation of ERK1 and 2, downstream targets for the activated EGFR. We found that e-Hsp72 indeed increased ERK1/2 phosphorylation and the effect was significantly enhanced by r-HspBP1. Again, r-HspBP1 alone did not promote ERK1/2 phosphorylation (Figure 4C ). These experiments demonstrate that eHsp72 activates the EGFR-ERK1/2 signalling pathway(s) and that HspBP1 can augment the e-Hsp72 signalling activity. It has been demonstrated that in vitro, HspBP1 accelerates the removal of nucleotides from Hsp72 and inhibits both ATPase and substrate-refolding activity of the latter (Kabani et al., 2002) . Therefore, it remains to be elucidated how eHspBP1 enhances the e-Hsp72 signalling function.
There is a considerable interest in the biological role of extracellular Hsp72. Signalling effects of eHsp72 have been referred to as a "chaperokine" function of Hsp72 (Asea, 2006) . It has been suggested that e-Hsp72 can have either a positive or negative effect on the host defence depending on unidentified modulating factors. An abundant cytoplasmic co-chaperone HspBP1 is known to modulate chaperone activity of intracellular Hsp72 and, in the present study, is shown to control e-Hsp72 signalling functions. Specifically, the present results demonstrated that: (i) HspBP1 is exported from A431 squamous carcinoma cells in response to the heat stress or U73122 treatment; (ii) both Hsp72 and HspBP1 escape cells using the secretory-like granules; (iii) e-Hsp72 and e-HspBP1 physically interact in the extracellular milieu, and (iv) e-HspBP1 enhances e-Hsp72-dependent phosphorylation of EGFR and ERK1/2. These results are important, considering
Figure 4 E-HspBP1 enhances e-Hsp72-mediated phosphorylation of EGFR and ERK1/2 (A) Western blotting analysis of anti-EGFR immunoprecipitates. Cells were treated, extracted and processed as described in the Materials and methods section. C, vehicletreated cells (control); 50, 100 and 1000 indicate amounts of r-HspBP1 (in ng/ml) incubated with cells; Hsp72, cells were incubated with 100 ng/ml of Hsp72 only; mutant HspBP1, cells were incubated with 100 ng/ml of Hsp72 and 65 ng/ml of HspBP1 N-terminal deletion mutant; boiled HspBP1, cells were incubated with 100 ng/ml of Hsp72 and 65 ng/ml of boiled r-HspBP1; HspBP1, cells were incubated with 100 ng/ml of Hsp72 and 65 ng/ml of r-HspBP1; heat shock, cells were heat stressed at 42
• C for 30 min. Membranes were stained with anti-phosphotyrosine that EGFR is one of the main regulators of cell proliferation, migration and tumorigenesis. EGFR overexpression in tumours, including human squamous carcinomas, usually indicates a poor prognosis for the patient. For that reason, EGFR inactivation is one of the most important goals in anti-cancer therapy. We believe that e-Hsp72/e-HspBP1-mediated autocrine mechanism of EGFR activation may present a unique point of entry for the development of novel anti-tumour treatments.
Materials and methods

Cell culture and treatment
A431 human squamous carcinoma cells (Russian Cell Culture Collection) were maintained in DMEM (Dulbecco's modified Eagle's medium) (Gibco) supplemented with 10% fetal calf serum at 37
• C in a humidified atmosphere with 5% CO 2 . For the experiments, A431 cells were grown in 10-cm-diameter tissue culture dishes at ∼80% confluence. The effect of temperature was examined by the incubation of cells at 42
• C in a humidified incubator for the indicated times. To detect HspBP1 in the culture medium, cells were washed once with DMEM, placed into fresh medium, and treated as indicated. After the treatment, the conditioned medium was collected, clarified by centrifugation for 5 min at 500 g, and then subjected to immunoprecipitation. For the cell viability determination, Trypan Blue dye was added to the cell cultures at a ratio of 1:1 for 10 min. Live/dead cell ratios were determined using a microscope. The tetrazolium salt (MTT) reduction assay was conducted as described by Denizot and Lang (1986) .
Reagents and antibodies
Protein G-Sepharose, reagents for electrophoresis, and secondary antibodies were from Sigma (St. Louis, MO, U.S.A.). U73122 and U73343 were purchased from Calbiochem (San Diego, CA, U.S.A.). Rabbit polyclonal anti-CgA antibody and mouse monoclonal anti-Hsp72 antibody were described in our previous study (Evdonin et al., 2004) . In addition, the following commercial antibodies were employed: polyclonal sheep anti-HspBP1 antibody (Novus Biologicals, Littleton, CO, U.S.A.); rabbit anti-EGFR (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.); anti-phosphotyrosine antibody (Transduction Laboratories, San Jose, CA, U.S.A.); mouse anti-α-tubulin antibody (Sigma); and rabbit anti-ERK1/2 and anti-phospho-ERK1/2 (Cell Signaling Technology, Danvers, MA, U.S.A.). All secondary antibodies used for the immunofluorescence were purchased from Amersham Biosciences. Anti-HspBP1 immunoglobulins were immobilized on agarose beads as described previously .
Proteins
Both human r-HspBP1 and the truncated form of HspBP1 (amino acids 84-359) were purified as previously described (McLellan et al., 2003) . Purified bovine skeletal muscle Hsp72 was provided by Dr Boris Margulis (Institute of Cytology, St. Petersburg, Russia). To remove possible contamination by endotoxin, Hsp72 preparation was treated with polymyxin Bagarose gel (Pierce) and filtered through 0.2 μm-pore microfilter (Sarstedt).
Immunoprecipitation, SDS/PAGE and Western blotting analysis
After the treatments, cells were washed with PBS (pH 7.4), extracted with ice-cold lysis buffer [20 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM DTT (dithiothreitol), 10% glycerol, 1% Triton X-100, 1% Nonidet P-40, 1 mM sodium orthovanadate, 10 μg/ml aprotinin, 10 μg/ml leupeptin and 1 mM PMSF], and centrifuged at 13 000 g for 10 min at 4
• C. Proteins from cell lysates or from conditioned media were immunoprecipitated with the indicated antibodies for 4 h at 4
• C. Protein G-agarose beads were then added for additional 90 min. Immunocomplexes were washed three times with the lysis buffer. Agarose beads were boiled in SDS loading buffer and eluted proteins were separated by SDS/PAGE and transferred to a PVDF membrane. Membranes were pre-incubated for 3 h at 4
• C in a blocking buffer consisting of TBS (Tris-buffered saline; 20 mM Tris/HCl and 150 mM NaCl), pH 7.6, 0.1% Tween 20, and 5% non-fat dry milk, and then were incubated with primary antibody for 1 h in TBS (pH 7.6) containing 0.05% Tween 20 and 5% BSA. Finally, membranes were incubated with the corresponding secondary antibodies conjugated with HRP. Immunopositive protein bands were visualized with the ECL detection system (Amersham).
Confocal fluorescent microscopy
Cells grown on glass coverslips were washed with PBS, fixed in 4% formaldehyde for 10 min, and permeabilized with 0.5% Triton X-100 in PBS. After three washes with PBS, cells were incubated for 1 h with blocking solution (1% BSA in PBS). Cells were then incubated for 40 min with either sheep anti-HspBP1 antibody (1:1000), mouse anti-Hsp72 antibody (1:500), or rabbit anti-CGA antibody (1:300). Coverslips were washed with PBS and then incubated for another 40 min with anti-sheep IgG-FITC (1:1000), anti-mouse IgG-Cy2 or anti-rabbit IgGCy3 respectively. The specimens were embedded in SlowFade reagent (Molecular Probes). Cells were viewed using a confocal microscope (LSM5 Pascal; Carl Zeiss, Inc.) with a 100/1.3 objective (Plan-Neofluar; Carl Zeiss, Inc.) at room temperature (18
• C). Images were acquired using a LSM5 Pascal camera and software (Carl Zeiss, Inc.), saved as lsm files, and processed using Photoshop CS2 (Adobe).
